BioE Ph.D. Defense Presentation- Victor Menezes
Advisor: Dr. Costas Arvanitis
(Woodruff School of Mechanical Engineering and Coulter Department of Biomedical Engineering)
Committee Members:
Dr. Levent Degertekin (Woodruff School of Mechanical Engineering)
Dr. Gabe Kwong (Coulter Department of Biomedical Engineering)
Dr. Ahmet Coskun (Coulter Department of Biomedical Engineering)
Dr. Anton Bryksin (Institute for Bioengineering and Bioscience)
Focused Ultrasound-enhanced Liquid Biopsy for Brain Cancer Diagnosis and Treatment Response Monitoring
Currentassessment of brain tumors is based either on imaging (MRI), which provides bulk information about tumor progression (e.g. size), or invasive and risky surgical procedures that are limited to a few timepoints. Liquid biopsy is a minimally invasive technique that uses cell-free DNA (cfDNA), in blood samples, to monitor tumor growth and response treatment at a molecular level. While this method is becoming increasingly important for clinical decisions across a range of tumors, it is particularly limited for brain tumors presumably due to the presence of the Blood-Brain Barrier (BBB), which tightly regulates the fluid flow (transport) of molecules between the tumor and the bloodstream.
Microbubble-enhanced focused ultrasound (MB-FUS) is a highly tunable technology that can reversibly open the BBB and enhance the transport of molecules across it. Hence, there lies the opportunity to combine MB-FUS with liquid biopsy techniques to monitor brain tumors. This research provides insights about the rate limiting biological variables for the detection of cancer soluble biomarkers (e.g. ctDNA, proteins) and establishes experimental protocols for using MB-FUS in combination with liquid biopsy for early diagnosis and monitoring targeted chemotherapy delivery in glioblastoma. Overall, our methods and mechanistic investigations contribute to a more thorough understanding of brain-derived biomarker secretion and responses to FUS treatment, creating unique opportunities for safer and more effective diagnosis, treatment, and treatment monitoring of brain cancer.